Willem de Vos

Icos Capital Management BV (ICM) is an independent private equity investment firm headquartered in Badhoevedorp, Netherlands. ICM is the investment manager of Icos Cleantech Fund I (also known as Dutch Technology Fund I) and Icos Cleantech Growth Fund II. Their first fund was co-founded by ICM, CSM, Imtech, Farm Frites, and also gets support from the Dutch Ministry of Economic Affairs.

Photanol BV produces biotechnology based commercial organic chemicals. It offers biofuels and organic compounds by using and combining the properties of photosynthetic and fermenting bacteria, solar energy and carbon dioxide. The company was founded by Klaas Hellingwerf and Joost Texeira de Mattos in 2008 and is headquartered in Amsterdam, the Netherlands.

BiOrion Technologies BV develops therapeutic drugs for the cancer and inflammatory diseases. It operates as a pre-clinical stage biopharmaceutical company that developing targeted therapies and companion imaging diagnostics for personalized treatment of patients with fibrosis. The firm develops advanced personalized medicine drugs for simultaneous diagnosis and treatment of diseases such as liver- and pancreatic cancer, liver cirrhosis and kidney fibrosis through specific targeting to PDGF- and IGF-II-expressing diseased cells. The company was founded by Martin Hessing, Klaas Poelstra and Herman Steen in 2003 and is headquartered in Groningen, the Netherlands.

AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands.

SERPINx BV develops and distributes protein therapeutics. The firm provides novel serine protease inhibitor (serpin) therapeutics for inflammatory-associated diseases. The company is headquartered in Utrecht, the Netherlands.